Search

Your search keyword '"Gangloff, Alice"' showing total 25 results
Start Over Author "Gangloff, Alice"
25 results on '"Gangloff, Alice"'

1. CEA, CA19-9, circulating DNA and circulating tumour cell kinetics in patients treated for metastatic colorectal cancer (mCRC)

Author

Sefrioui, David, Beaussire, Ludivine, Gillibert, André, Blanchard, France, Toure, Emmanuel, Bazille, Céline, Perdrix, Anne, Ziegler, Frédéric, Gangloff, Alice, Hassine, Mélanie, Elie, Caroline, Bignon, Anne-Laure, Parzy, Aurélie, Gomez, Philippe, Thill, Caroline, Clatot, Florian, Sabourin, Jean-Christophe, Frebourg, Thierry, Benichou, Jacques, Bouhier-Leporrier, Karine, Gallais, Marie-Pierre, Sarafan-Vasseur, Nasrin, Michel, Pierre, and Di Fiore, Frédéric

Published
2021
Full Text
View/download PDF

3. Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trial

Author

Moussata, Driffa, Grangé, Jean-Didier, Ratziu, Vlad, Khemissa-Akouz, Faiza, Regnault, Hélène, Dauvois, Barbara, Zarski, Jean-Pierre, Ollivier-Hourmand, Isabelle, Manfredi, Sylvain, Debette-Gratien, Marilyne, Gangloff, Alice, Fontanges, Thierry, Baron, Aurore, Bouattour, Mohamed, Vincent, Julie, Sieghart, Wolfgang, Maieron, Andreas, Peeters, Marc, Delwaide, Jean, Lasser, Luc, Berg, Thomas, Schultheiß, Michael, Zipprich, Alexander, Trojan, Joerg, Ehmer, Ursula, Luppi, Gabriele, Luca, Giovanni, Tamberi, Stefano, Amoroso, Domenico, Alabiso, Oscar, Buonadonna, Angela, Toniutto, Pierluigi, Tamburini, Emiliano, Cubillo, Antonio, Muñoz, Andrés, Guillén, Carmen, Sánchez, Gloria, Manzano, Hermini, Navarro, Victor, Ales, Inmaculada, Massuti, Bartomeu, Dank, Magdolna, Bodoky, György, Kahan, Zsuzsanna, Horváth, Zsolt, Gabrail, Nashat, Ozer, Howard, Galanopoulos, Christos, Hauke, Ralph, Raj, Moses, Harputluoglu, Hakan, Sevinc, Alper, Goker, Erdem, Coker, Ahmet, Yalcin, Suayib, Ali, Muhammet, Ata, Ozlem, Tugba, Ilkay, El Kassas, Mohammed, Abdel, Amr, Wakid, Imam, Shamaa, Sameh, El Lahlouby, Nasr, Kohail, Hanaa, Makarem, Jawad, Chehade, Issam, Farhat, Fadi, López, Carlos, Marín, Miguel, Merle, Philippe, Blanc, Jean-Frederic, Phelip, Jean-Marc, Pelletier, Gilles, Bronowicki, Jean-Pierre, Touchefeu, Yann, Pageaux, Georges, Gerolami, René, Habersetzer, François, Nguyen-Khac, Eric, Casadei-Gardini, Andrea, Borbath, Ivan, Tran, Albert, Wege, Henning, Saad, Amr Shafik, Colombo, Massimo, Abergel, Armand, Richou, Carine, Waked, Imam, Yee, Nelson S, Molé, Audrey, Attali, Pierre, Le Boulicaut, Julie, and Vasseur, Bérangère

Published
2019
Full Text
View/download PDF

5. Evaluating bevacizumab in combination with FOLFIRI after the failure of platinum-etoposide regimen in patients with advanced poorly differentiated neuroendocrine carcinoma: The PRODIGE 41–BEVANEC randomized phase II study

Author

Walter, Thomas, Malka, David, Hentic, Olivia, Lombard-Bohas, Catherine, Le Malicot, Karine, Smith, Denis, Ferru, Aurélie, Assenat, Eric, Cadiot, Guillaume, Lievre, Astrid, Kurtz, Jean-Emmanuel, Dahan, Laetitia, Dubreuil, Olivier, Hautefeuille, Vincent, Lepere, Céline, Gangloff, Alice, Elhajbi, Farid, Coriat, Romain, Roquin, Guillaume, Bouarioua, Nadia, Granger, Victoire, Scoazec, Jean-Yves, and Lepage, Côme

Published
2018
Full Text
View/download PDF

9. Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis

Author

De Roock, Wendy, Claes, Bart, Bernasconi, David, De Schutter, Jef, Biesmans, Bart, Fountzilas, George, Kalogeras, Konstantine T, Kotoula, Vassiliki, Papamichael, Demetris, Laurent-Puig, Pierre, Penault-Llorca, Frédérique, Rougier, Philippe, Vincenzi, Bruno, Santini, Daniele, Tonini, Giuseppe, Cappuzzo, Federico, Frattini, Milo, Molinari, Francesca, Saletti, Piercarlo, De Dosso, Sara, Martini, Miriam, Bardelli, Alberto, Siena, Salvatore, Sartore-Bianchi, Andrea, Tabernero, Josep, Macarulla, Teresa, Di Fiore, Frédéric, Gangloff, Alice Oden, Ciardiello, Fortunato, Pfeiffer, Per, Qvortrup, Camilla, Hansen, Tine Plato, Van Cutsem, Eric, Piessevaux, Hubert, Lambrechts, Diether, Delorenzi, Mauro, and Tejpar, Sabine

Published
2010
Full Text
View/download PDF

10. Circulating DNA changes are predictive of disease progression after transarterial chemoembolization

Author

Sefrioui, David, primary, Verdier, Vincent, additional, Savoye‐Collet, Céline, additional, Beaussire, Ludivine, additional, Ghomadi, Slim, additional, Gangloff, Alice, additional, Goria, Odile, additional, Riachi, Ghassan, additional, Montialoux, Hélène, additional, Schwarz, Lilian, additional, Tuech, Jean‐Jacques, additional, Frebourg, Thierry, additional, Michel, Pierre, additional, Sarafan‐Vasseur, Nasrin, additional, and Di Fiore, Frédéric, additional

Published
2021
Full Text
View/download PDF

13. Circulating DNA changes are predictive of disease progression after transarterial chemoembolization.

Author

Sefrioui, David, Verdier, Vincent, Savoye‐Collet, Céline, Beaussire, Ludivine, Ghomadi, Slim, Gangloff, Alice, Goria, Odile, Riachi, Ghassan, Montialoux, Hélène, Schwarz, Lilian, Tuech, Jean‐Jacques, Frebourg, Thierry, Michel, Pierre, Sarafan‐Vasseur, Nasrin, and Di Fiore, Frédéric

Subjects
CIRCULATING tumor DNA, CELL-free DNA, CHEMOEMBOLIZATION, MAGNETIC resonance imaging, HEPATOCELLULAR carcinoma, RECEIVER operating characteristic curves, DISEASE progression
Abstract

Transarterial chemoembolization (TACE) is used to treat patients with unresectable hepatocellular carcinoma (HCC). We evaluated the clinical impact of a‐fetoprotein (AFP) and circulating cell‐free and tumor DNA (cfDNA and ctDNA) changes around the TACE procedure. Our prospective monocentric study enrolled consecutive patients treated with TACE, with samples collected at baseline (D − 1), Day 2 (D + 2) and 1 month (M + 1) after TACE. cfDNA was quantified by the fluorometric method, and ctDNA was quantified by digital polymerase chain reaction designed for two hotspot TERT mutations. Computerized tomography scans or magnetic resonance imaging were performed at M + 1 every 3 months following TACE and independently reviewed. The objective was to identify thresholds of cfDNA, ctDNA and AFP changes associated with progressive disease (PD) using receiver operating characteristic curves. Thirty‐eight patients were included from March 2018 to March 2019. All markers significantly increased from D − 1 to D + 2 (P <.005), and cfDNA and ctDNA significantly decreased from D + 2 to M + 1 (P <.0001). The analysis of changes from D − 1 to M + 1 identified thresholds at +31.4% for cfDNA and 0% for ctDNA that were significantly associated with PD at M + 1 (44.4% [>+31.4%] vs 3.8% [≤+31.4%] and 50.0% [>0%] vs 5.0% [≤0%], respectively). No significant threshold was identified for AFP. Using a score combining cfDNA and ctDNA, the patients were classified into high‐ or low‐risk PD groups at M + 1, with PD rates of 80.0% vs 4.3% (P =.001) and median progression‐free survival times of 1.3 vs 10.3 months (P =.002). Our study suggests that cfDNA and ctDNA increases around the TACE procedure and are associated with therapeutic failure. What's new? Transarterial chemoembolization (TACE) is recommended as the first line of treatment for intermediate‐stage hepatocellular carcinoma, but efficacy assessment methods need to be improved. This prospective study evaluates the clinical impact of a‐fetoprotein and circulating cell‐free and tumor DNA changes around the TACE procedure. The results suggest that circulating cell‐free and tumor DNA dynamics may represent a promising marker to help evaluate treatment strategies after a first TACE procedure. A significant peak release of circulating DNA markers was observed after TACE, with a circulating tumor DNA detection rate at Day 2 that was almost twice as high as that at baseline. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

15. Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trial

Author

Merle, Philippe, primary, Blanc, Jean-Frederic, additional, Phelip, Jean-Marc, additional, Pelletier, Gilles, additional, Bronowicki, Jean-Pierre, additional, Touchefeu, Yann, additional, Pageaux, Georges, additional, Gerolami, René, additional, Habersetzer, François, additional, Nguyen-Khac, Eric, additional, Casadei-Gardini, Andrea, additional, Borbath, Ivan, additional, Tran, Albert, additional, Wege, Henning, additional, Saad, Amr Shafik, additional, Colombo, Massimo, additional, Abergel, Armand, additional, Richou, Carine, additional, Waked, Imam, additional, Yee, Nelson S, additional, Molé, Audrey, additional, Attali, Pierre, additional, Le Boulicaut, Julie, additional, Vasseur, Bérangère, additional, Moussata, Driffa, additional, Grangé, Jean-Didier, additional, Ratziu, Vlad, additional, Khemissa-Akouz, Faiza, additional, Regnault, Hélène, additional, Dauvois, Barbara, additional, Zarski, Jean-Pierre, additional, Ollivier-Hourmand, Isabelle, additional, Manfredi, Sylvain, additional, Debette-Gratien, Marilyne, additional, Gangloff, Alice, additional, Fontanges, Thierry, additional, Baron, Aurore, additional, Bouattour, Mohamed, additional, Vincent, Julie, additional, Sieghart, Wolfgang, additional, Maieron, Andreas, additional, Peeters, Marc, additional, Delwaide, Jean, additional, Lasser, Luc, additional, Berg, Thomas, additional, Schultheiß, Michael, additional, Zipprich, Alexander, additional, Trojan, Joerg, additional, Ehmer, Ursula, additional, Luppi, Gabriele, additional, Luca, Giovanni, additional, Tamberi, Stefano, additional, Amoroso, Domenico, additional, Alabiso, Oscar, additional, Buonadonna, Angela, additional, Toniutto, Pierluigi, additional, Tamburini, Emiliano, additional, Cubillo, Antonio, additional, Muñoz, Andrés, additional, Guillén, Carmen, additional, Sánchez, Gloria, additional, Manzano, Hermini, additional, Navarro, Victor, additional, Ales, Inmaculada, additional, Massuti, Bartomeu, additional, Dank, Magdolna, additional, Bodoky, György, additional, Kahan, Zsuzsanna, additional, Horváth, Zsolt, additional, Gabrail, Nashat, additional, Ozer, Howard, additional, Galanopoulos, Christos, additional, Hauke, Ralph, additional, Raj, Moses, additional, Harputluoglu, Hakan, additional, Sevinc, Alper, additional, Goker, Erdem, additional, Coker, Ahmet, additional, Yalcin, Suayib, additional, Ali, Muhammet, additional, Ata, Ozlem, additional, Tugba, Ilkay, additional, El Kassas, Mohammed, additional, Abdel, Amr, additional, Wakid, Imam, additional, Shamaa, Sameh, additional, El Lahlouby, Nasr, additional, Kohail, Hanaa, additional, Makarem, Jawad, additional, Chehade, Issam, additional, Farhat, Fadi, additional, López, Carlos, additional, and Marín, Miguel, additional

Published
2019
Full Text
View/download PDF

16. Copy number variations in DCC/ 18q and ERBB2/ 17q are associated with disease-free survival in microsatellite stable colon cancer

Author

Sefrioui , France, Vermeulin , France, Blanchard , France, Chapusot , Caroline, Beaussire , Ludivine, Armengol-Debeir , Laura, Sesboué , Richard, Gangloff , Alice, Hebbar , Mohamed, Copin , Marie-Christine, Houivet , Estelle, Schwarz , Lilian, Clatot , Florian, Tuech , Jacques, Bénichou , Jacques, Martin , Laurent, Bouvier , Anne-Marie, Sabourin , Jean-Christophe, Sarafan-Vasseur , Nasrin, Frébourg , Thierry, Lepage , Côme, Michel , Pierre, Di Fiore , Frédéric, Génétique du cancer et des maladies neuropsychiatriques (GMFC), Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Normandie Université (NU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Génomique et Médecine Personnalisée du Cancer et des Maladies Neuropsychiatriques (GPMCND), Hôpital Charles Nicolle [Tunis], Service de génétique [Rouen], CHU Rouen, Normandie Université (NU)-Normandie Université (NU)-Université de Rouen Normandie (UNIROUEN), Normandie Université (NU), Lipides - Nutrition - Cancer (U866) (LNC), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Bourgogne (UB)-Ecole Nationale Supérieure de Biologie Appliquée à la Nutrition et à l'Alimentation de Dijon (ENSBANA)-AgroSup Dijon - Institut National Supérieur des Sciences Agronomiques, de l'Alimentation et de l'Environnement, Service d'Hépato-Gastroentérologie [CHU Rouen], Hôpital Charles Nicolle [Rouen]-CHU Rouen, Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Service de Pathologie, PRES Université Lille Nord de France-Faculté de Médecine Henri Warembourg-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Hôpital Charles Nicolle [Rouen], Groupe d'étude des proliférations lymphoïdes (GPL), Unité de biostatistiques [CHU Rouen], Centre Guillaume le Conquérant, Service d'Anatomie et Cytologie Pathologique [CHU Rouen], Département d'oncologie médicale [Rouen], Centre de Lutte Contre le Cancer Henri Becquerel Normandie Rouen (CLCC Henri Becquerel), Génétique du cancer et des maladies neuropsychiatriques ( GMFC ), Université de Rouen Normandie ( UNIROUEN ), Normandie Université ( NU ) -Normandie Université ( NU ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ), Service d'Hépato-Gastroentérologie [Rouen], Normandie Université ( NU ) -Normandie Université ( NU ) -Hôpital Charles Nicolle [Rouen]-CHU Rouen, Unité de biostatistiques [Rouen], CHU Rouen-Université de Rouen Normandie ( UNIROUEN ), Normandie Université ( NU ) -Normandie Université ( NU ), Service de Pathologie [CHU de Dijon], Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand ( CHU Dijon ), Service d'oncologie médicale (CHRU Lille), Centre Hospitalier Régional Universitaire [Lille] ( CHRU Lille ), Service de pathologie [CHU Lille], Département de chirurgie [Rouen], CRLCC Henri Becquerel, Service de chirurgie digestive [Rouen], Registre Bourguignon des Cancers Digestifs, Lipides - Nutrition - Cancer (U866) ( LNC ), Université de Bourgogne ( UB ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -AgroSup Dijon - Institut National Supérieur des Sciences Agronomiques, de l'Alimentation et de l'Environnement-Ecole Nationale Supérieure de Biologie Appliquée à la Nutrition et à l'Alimentation de Dijon ( ENSBANA ) -Université de Bourgogne ( UB ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -AgroSup Dijon - Institut National Supérieur des Sciences Agronomiques, de l'Alimentation et de l'Environnement-Ecole Nationale Supérieure de Biologie Appliquée à la Nutrition et à l'Alimentation de Dijon ( ENSBANA ) -Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand ( CHU Dijon ), Service d'Oncologie Médicale, and Centre de Lutte Contre le Cancer Henri Becquerel Normandie Rouen ( CLCC Henri Becquerel )

Subjects
Male, Proto-Oncogene Proteins B-raf, MESH: Colon Cancer, DNA Copy Number Variations, Receptor, ErbB-2, MESH: Chromosomal instability, [SDV]Life Sciences [q-bio], DNA Mutational Analysis, MESH: Copy Number Variation, Loss of Heterozygosity, Receptors, Cell Surface, Polymerase Chain Reaction, Disease-Free Survival, [ SDV.CAN ] Life Sciences [q-bio]/Cancer, Humans, Prospective Studies, Neoplasm Metastasis, Aged, Proportional Hazards Models, Colon Cancer, Tumor Suppressor Proteins, Carcinoma, Middle Aged, DCC Receptor, Prognosis, Copy Number Variation, Chromosomal instability, Microstellite Stable, Phenotype, Treatment Outcome, Colonic Neoplasms, MESH: Disease-Free Survival, Female, MESH: Microstellite Stable, Neoplasm Recurrence, Local, Microsatellite Repeats
Abstract

IF 5.531; International audience; We conducted a prospective study to assess the prognostic impact of selected copy number variations (CNVs) in stage II-III microsatellite stable (MSS) colon cancer. A total of 401 patients were included from 01/2004 to 01/2009. The CNVs in 8 selected target genes, DCC/18q, EGFR/7p, TP53/17p, BLK/8p, MYC/8q, APC/5q, ERBB2/17q, and STK6/20q, were detected using a quantitative multiplex polymerase chain reaction of short fluorescent fragment (QMPSF) method. The primary end-point was the impact of the CNVs on the 4-year disease-free survival (DFS). The recurrence rate at 4 years was 20.9%, corresponding to 14% stage II patients vs 31% stage III patients (p

Published
2017
Full Text
View/download PDF

18. Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours

Author

Sefrioui, David, primary, Blanchard, France, additional, Toure, Emmanuel, additional, Basile, Paul, additional, Beaussire, Ludivine, additional, Dolfus, Claire, additional, Perdrix, Anne, additional, Paresy, Marianne, additional, Antonietti, Michel, additional, Iwanicki-Caron, Isabelle, additional, Alhameedi, Raied, additional, Lecleire, Stephane, additional, Gangloff, Alice, additional, Schwarz, Lilian, additional, Clatot, Florian, additional, Tuech, Jean-Jacques, additional, Frébourg, Thierry, additional, Jardin, Fabrice, additional, Sabourin, Jean-Christophe, additional, Sarafan-Vasseur, Nasrin, additional, Michel, Pierre, additional, and Di Fiore, Frédéric, additional

Published
2017
Full Text
View/download PDF

19. Copy number variations in DCC/18q and ERBB2/17q are associated with disease‐free survival in microsatellite stable colon cancer

Author

Sefrioui, David, primary, Vermeulin, Thomas, additional, Blanchard, France, additional, Chapusot, Caroline, additional, Beaussire, Ludivine, additional, Armengol‐Debeir, Laura, additional, Sesboué, Richard, additional, Gangloff, Alice, additional, Hebbar, Mohamed, additional, Copin, Marie‐Christine, additional, Houivet, Estelle, additional, Schwarz, Lilian, additional, Clatot, Florian, additional, Tuech, Jean‐Jacques, additional, Bénichou, Jacques, additional, Martin, Laurent, additional, Bouvier, Anne‐Marie, additional, Sabourin, Jean‐Christophe, additional, Sarafan‐Vasseur, Nasrin, additional, Frébourg, Thierry, additional, Lepage, Côme, additional, Michel, Pierre, additional, and Di Fiore, Frédéric, additional

Published
2017
Full Text
View/download PDF

20. Prospective analysis of CEA, circulating DNA (cDNA) and circulating tumor cells (CTC) kinetics in patients (pts) treated for a metastatic colorectal cancer (mCRC).

Author

Sefrioui, David, primary, Sarafan-Vasseur, Nasrin, additional, Toure, Emmanuel, additional, Delacour, Julien, additional, Ziegler, Frederic, additional, Thill, Caroline, additional, Gangloff, Alice, additional, Blanchard, France, additional, Beaussire, Ludivine, additional, Bouhier Leporrier, Karine, additional, Galais, Marie-Pierre, additional, Perdrix, Anne, additional, Clatot, Florian, additional, Jardin, Fabrice, additional, Sabourin, Jean-Christophe, additional, Frébourg, Thierry, additional, Michel, Pierre, additional, and Di Fiore, Frédéric, additional

Published
2016
Full Text
View/download PDF

21. Conception d'une application mobile d'aide à la prise en charge en hépato-gastroentérologie à destination des internes : le projet « GastroHelp ».

Author

Lazartigues, Julien, Gangloff, Alice, Hassine, Mélanie, Daveau, Mathieu, Michel, Pierre, Di Fiore, Frédéric, and Savoye, Guillaume

Abstract

Smartphone's fast growth and success have heavily changed the daily life of healthcare professionals by easing their access to knowledge. We discuss in this article the birth and progress of the "GastroHelp" project: the making of a mobile health application on smartphone/tablet to Hepato-Gastro-Enterology residents. The project aims to make a patient management guide in the field of Gastro-Enterology on a mobile application destined to residents in our specialty. Programming, application architecture and graphic design were realized by two professionals (a developer and a graphic designer). The "GastroHelp" application is almost technically completed. The content (scalable) was written according to the Haute Autorité de Santé guidelines as well as dmdSanté company's guide of good practice in the conception and development of mobile health applications. The content is currently under review. Inherent medico-legal issues due to mobile health applications are significant and have to be contained with the help of legal professionals. The estimated budget is 34 000 € and we are in search of financing to enable the beta test launch in the next few months. [ABSTRACT FROM AUTHOR]

Published
2018
Full Text
View/download PDF

22. PRODIGE 20: Bevacizumab + chemotherapy (BEV-CT) versus chemotherapy alone (CT) in elderly patients (pts) with untreated metastatic colorectal cancer (mCRC)—A randomized phase II trial.

Author

Aparicio, Thomas, primary, Bouche, Olivier, additional, Francois, Eric, additional, Maillard, Emilie, additional, Kirscher, Sylvie, additional, Taïeb, Julien, additional, Etienne, Pierre-Luc, additional, Faroux, Roger, additional, Khemissa, Faiza, additional, El Hajbi, Farid, additional, Locher, Christophe, additional, Rinaldi, Yves, additional, Lecomte, Thierry, additional, Lavau-Denes, Sandrine, additional, Baconnier, Mathieu, additional, Oden-Gangloff, Alice, additional, Genet, Dominique, additional, Paillaud, Elena, additional, Retornaz, Frederic, additional, and Bedenne, Laurent, additional

Published
2015
Full Text
View/download PDF

23. Primary prophylactic granulocyte colony-stimulating factor (GCSF) in Gilbert’s disease patients treated with FOLFIRI first line for metastatic colorectal cancer (mCRC): Final results of the FFCD 0604 study.

Author

Lecomte, Thierry, primary, Bouche, Olivier, additional, oden-Gangloff, Alice, additional, Le Malicot, Karine, additional, Aparicio, Thomas, additional, Mitry, Emmanuel, additional, Bedenne, Laurent, additional, Deplanque, Gael, additional, Volet, Julien, additional, Tougeron, David, additional, Bonnetain, Franck, additional, Moreau, Marie, additional, Dorval, Etienne, additional, Loriot, Marie-Anne, additional, Laurent-Puig, Pierre, additional, and Lepage, Come, additional

Published
2013
Full Text
View/download PDF

24. Usefulness of circulating tumor cell detection in pancreatic adenocarcinoma diagnosis.

Author

Basile, Paul, primary, iwanicki-Caron, Isabelle, additional, Toure, Emmanuel, additional, Antonietti, Michel, additional, Lecleire, Stephane, additional, Di Fiore, Aude, additional, oden-Gangloff, Alice, additional, Blanchard, France, additional, Lemoine, Francoise, additional, Di Fiore, Frédéric, additional, Sabourin, Jean-Christophe, additional, and Michel, Pierre, additional

Published
2013
Full Text
View/download PDF

25. Usefulness of Circulating Tumor Cell Detection in Pancreatic Adenocarcinoma Diagnosis

Author

Iwanicki-Caron, Isabelle, primary, Basile, Paul, additional, Toure, Emmanuel, additional, Antonietti, Michel, additional, Lecleire, Stephane, additional, Di Fiore, Aude, additional, Oden-Gangloff, Alice, additional, Blanchard, France, additional, Lemoine, Francoise, additional, Di Fiore, Frederic, additional, Sabourin, Jean Christophe, additional, and Michel, Pierre, additional

Published
2013
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results